Additionally, preclinical studies by Chen et al. demonstrated that a specific CTSS inhibitor, RJW-58, can mitigate peripheral neuropathy through immunomodulatory mechanisms [55]. The gene discussed is CTSS; the disease is peripheral neuropathy.